mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.008 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.009 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.009 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.009 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.01 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.01 |